Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009–2021

Update your browser to view ScienceDirect.

Request details:

Request ID: 8bfbf193aee96464-LAX
IP: 116.62.10.13
UTC time: 2024-09-08T03:45:04+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4